Literature DB >> 17509984

Hepatosplenic and other gammadelta T-cell lymphomas.

Francisco Vega1, L Jeffrey Medeiros, Philippe Gaulard.   

Abstract

The 2005 Society for Hematopathology/European Association for Haematopathology Workshop session 11 was dedicated to hepatosplenic T-cell lymphoma (HSTCL). HSTCL is a rare aggressive type of extranodal lymphoma characterized by hepatosplenomegaly, bone marrow involvement, and peripheral blood cytopenias. HSTCL exhibits a distinctive pattern of infiltration; tumor cells preferentially infiltrate the sinusoids of the splenic red pulp, liver, and bone marrow. The tumor cells have a nonactivated cytotoxic T-cell immunophenotype and frequently carry a recurrent cytogenetic abnormality, isochromosome 7q. Most cases express the gammadelta T-cell receptor, but cases can have an alphabeta phenotype and are considered to be a variant of the disease. Although HSTCL is the prototype peripheral T-cell lymphoma expressing the gammadelta T-cell receptor, non-HSTCL proliferations of gammadelta T cells can involve other extranodal sites, mainly skin and mucosa. These gammadelta T-cell lymphomas display marked heterogeneity in clinical and histologic features. In contrast with HSTCL, non-HSTCL gammadelta T-cell lymphomas frequently have an activated cytotoxic phenotype and most likely are not a single disease entity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509984     DOI: 10.1309/LRKX8CE7GVPCR1FT

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  24 in total

1.  Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.

Authors:  Adriana Garcia-Herrera; Joo Y Song; Shih-Sung Chuang; Neus Villamor; Luis Colomo; Stefania Pittaluga; Tomas Alvaro; Maria Rozman; Jazmin de Anda Gonzalez; Ana Maria Arrunategui; Eva Fernandez; Elena Gonzalvo; Teresa Estrach; Dolors Colomer; Mark Raffeld; Philippe Gaulard; Elias Campo; Elaine S Jaffe; Antonio Martinez
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

2.  Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.

Authors:  Orly R Klein; Jessica Buddenbaum; Noah Tucker; Allen R Chen; Christopher J Gamper; David Loeb; Elias Zambidis; Nicolas J Llosa; Jeffrey S Huo; Nancy Robey; Mary Jo Holuba; Yvette L Kasamon; Shannon R McCurdy; Richard Ambinder; Javier Bolaños-Meade; Leo Luznik; Ephraim J Fuchs; Richard J Jones; Kenneth R Cooke; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-22       Impact factor: 5.742

3.  Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party.

Authors:  A Tanase; N Schmitz; H Stein; A Boumendil; H Finel; L Castagna; D Blaise; N Milpied; G Sucak; A Sureda; K Thomson; E Vandenberghe; A Vitek; P Dreger
Journal:  Leukemia       Date:  2014-09-19       Impact factor: 11.528

4.  Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.

Authors:  Ching-Hon Pui; Deqing Pei; Cheng Cheng; Suzanne L Tomchuck; Scarlett N Evans; Hiroto Inaba; Sima Jeha; Susana C Raimondi; John K Choi; Paul G Thomas; Mari Hashitate Dallas
Journal:  Oncoimmunology       Date:  2019-05-17       Impact factor: 8.110

Review 5.  Peripheral T and NK cell non-hodgkin lymphoma a challenge for diagnosis.

Authors:  Daniela Vasile; Ana-Maria Vladareanu; Horia Bumbea
Journal:  Maedica (Buchar)       Date:  2014-03

Review 6.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

7.  Hepatosplenic T Cell Lymphoma in an Immunocompetent Female Diagnosed using Flow Cytometry: A Rare Clinical Entity.

Authors:  Pranav Dorwal; Ritesh Sachdev; Amit Pande; Dharmendra Jain; Bhawna Jha; Vimarsh Raina
Journal:  J Clin Diagn Res       Date:  2016-08-01

8.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

9.  Gamma/delta T-cell lymphoma in a dog.

Authors:  Petra Borska; Martin Faldyna; Jan Blatny; Lenka Leva; Monika Vejrostova; Jaroslav Doubek; Peter F Moore
Journal:  Can Vet J       Date:  2009-04       Impact factor: 1.008

Review 10.  Pathobiology of T-cell and NK-cell lymphomas.

Authors:  Ewa B Bajor-Dattilo; Stefania Pittaluga; Elaine S Jaffe
Journal:  Best Pract Res Clin Haematol       Date:  2013-05-23       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.